Nuo Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AURX | ANIX | TENX | PTX.AX | HEM.V | MREO | |
|---|---|---|---|---|---|---|
| Market cap | 61.51M | 114.03M | 67.74M | 60.62M | 11.63M | 48.40M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -127.0 | -10.6 | -1.2 | 5.3 | -0.4 | -13.1 |
| Price/book | -39.7 | 7.8 | 0.8 | 3.8 | -2.0 | 1.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −45.96% | −24.82% | −73.84% | +10.87% | −47.37% | −82.78% |
| Today | 0.00% | +7.36% | −1.63% | +3.92% | +10.00% | +4.16% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All AURX news ›Nuo Therapeutics closes $325K loan, reaches $2M
Director Scott M. Pittman lent $125,000 in the second funding. Four lenders assumed $25,000 each; the notes mature December 31, 2028. Nuo Therapeutics closes $325K loan, reaches $2M The warrant assignment reallocates coverage on the…
Nuo Therapeutics director acquires 4,500-share warrant
A director acquires warrants for 4,500 Nuo Therapeutics (AURX) shares with a $1.50 exercise price. Stock Titan - [Form 4] Nuo Therapeutics, Inc. Insider Trading Activity Nuo Therapeutics director acquires 4,500-share warrant The 458-share…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.